Stanley Jack Cherelstein - Net Worth and Insider Trading

Stanley Jack Cherelstein Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Stanley Jack Cherelstein owns 1 companies in total, including Nutra Pharma Corp (NPHC) .

Click here to see the complete history of Stanley Jack Cherelstein’s form 4 insider trades.

Insider Ownership Summary of Stanley Jack Cherelstein

Ticker Comapny Transaction Date Type of Owner
NPHC Nutra Pharma Corp 2004-11-05 director

Stanley Jack Cherelstein Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Stanley Jack Cherelstein Ownership Network

Ownership Network List of Stanley Jack Cherelstein

No Data

Ownership Network Relation of Stanley Jack Cherelstein

Insider Network Chart

Stanley Jack Cherelstein Owned Company Details

What does Nutra Pharma Corp do?

Who are the key executives at Nutra Pharma Corp?

Stanley Jack Cherelstein is the director of Nutra Pharma Corp. Other key executives at Nutra Pharma Corp include Chief Executive Officer Rik J Deitsch , other: Former CFO Bruno Sartori , and director & President - ReceptoPharm Harold Henry Rumph .

Nutra Pharma Corp (NPHC) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Nutra Pharma Corp (NPHC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Nutra Pharma Corp (NPHC) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Nutra Pharma Corp (NPHC)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Nutra Pharma Corp Insider Transactions

No Available Data

Stanley Jack Cherelstein Mailing Address

Above is the net worth, insider trading, and ownership report for Stanley Jack Cherelstein. You might contact Stanley Jack Cherelstein via mailing address: 2401 Sw Manor Hill Drive, Palm City Fl 34990.

Discussions on Stanley Jack Cherelstein

No discussions yet.